Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/30/2013CN102813624B Lidocaine ethosome and preparation method thereof
10/30/2013CN102697711B Desloratadine oral liquid preparation and preparation method thereof
10/30/2013CN102631682B Graphene oxide and sanguinarine compound and preparation method thereof
10/30/2013CN102618600B Method for preparing spring dextrin by aid of alpha amylase for hydrolyzing amylose starch
10/30/2013CN102596195B Water-based paste containing diclofenac sodium
10/30/2013CN102579395B Lipoic acid capsules as well as preparation process and application thereof
10/30/2013CN102552645B Kidney-tonifying and yang-strengthening health-care medicament and preparation method thereof
10/30/2013CN102526112B Sustained-release pearl clear-sighted eye drops and preparation method thereof
10/30/2013CN102525995B Plant officinal hollow capsule and preparation method thereof
10/30/2013CN102504045B Modified chitosan temperature-sensitive supramolecular gel based on host-guest property of cucurbituril, and preparation method and application thereof
10/30/2013CN102485210B Voriconazole intravenous injection submicron emulsion and its preparation method
10/30/2013CN102475683B Liposome which is prepared by ion-exchange fiber and has internal and external water phase gradient difference and application thereof
10/30/2013CN102274160B Method and preparation for treating resistance to antihypertensives and related conditions
10/30/2013CN102240290B Pharmaceutical composition containing prulifloxacin, and preparation method thereof
10/30/2013CN102198271B Method for preparing medicament-nanometer calcium phosphate composite system taking fat soluble photosensitizer as framework and application of system in preparation of medicaments for photodynamic therapy
10/30/2013CN102151331B Polysaccharide-protein conjugate vaccines
10/30/2013CN102145173B Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof
10/30/2013CN102115448B Admantyl quaternary ammonium base and preparation method thereof
10/30/2013CN102028953B Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
10/30/2013CN101951923B Liquid nucleotides/nucleosides-containing product
10/30/2013CN101809038B Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
10/30/2013CN101790372B Method and composition for making orally disintegrating dosage form
10/30/2013CN101707930B Pharmaceutical formulation for production of rapidly disintegrating tablets
10/30/2013CN101557802B Self solidifying bioerodible barrier implant
10/30/2013CN101557801B Hydrogels containing low molecular weight alginates and biostructures made therefrom
10/30/2013CN101415464B Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
10/30/2013CN101247834B Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
10/30/2013CN101044242B Tumor specific antibody
10/29/2013US8569480 Hydroxyethylstarch
10/29/2013US8569385 Hydrolysis resistant organomodified silylated ionic surfactants
10/29/2013US8569272 Methods for treating a posterior segment of an eye
10/29/2013US8569239 Glutathione based delivery system
10/29/2013US8569078 Magnetic-nanoparticle conjugates and methods of use
10/29/2013US8568780 Pharmaceutical formulation for the production of rapidly disintegrating tablets
10/29/2013US8568777 Packaged film dosage unit containing a complexate
10/29/2013US8568773 Glycerophospholipids for the improvement of cognitive functions
10/29/2013US8568767 Dietary fiber composition
10/29/2013US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof
10/29/2013US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides
10/29/2013US8568701 Cationic synthetic polymers with improved solubility and performance in phosphate surfactant-based systems and use in personal care and household applications
10/29/2013CA2680825C Topical formulations having enhanced bioavailability
10/29/2013CA2671975C Film-coated preparation having improved stability
10/29/2013CA2622624C Topical film-forming monophasic formulations
10/29/2013CA2605473C Process for preparing quetiapine and quetiapine fumarate
10/29/2013CA2549409C Glycopegylated granulocyte colony stimulating factor
10/29/2013CA2544965C Heat moisture treated starch for the treatment of hypoglycaemia
10/29/2013CA2511512C Immunogenic compositions containing phospholipid
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2442363C Reducing the immunogenicity of fusion proteins
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/24/2013WO2013159029A1 Compositions for topical treatment of microbial infections
10/24/2013WO2013159021A1 Engineered collagen binding mscramm with enhanced affinity for collagen
10/24/2013WO2013158992A1 Highly branched alpha-d-glucans
10/24/2013WO2013158895A1 Novel echogenic contrast agents
10/24/2013WO2013158719A1 Use of non-metallic cest agents for mri monitoring of nanoparticle delivery
10/24/2013WO2013158644A2 Targeted therapeutics
10/24/2013WO2013158618A1 Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
10/24/2013WO2013158318A1 Formulations and methods for treatment of acne and inflammatory skin conditions
10/24/2013WO2013158317A1 Formulations and methods for treatment of inflammatory skin diseases
10/24/2013WO2013158278A1 Compositions and methods comprising energy absorbing materials for follicular delivery
10/24/2013WO2013157841A1 Sustained release tablet containing levodropropizine and method for preparing same
10/24/2013WO2013157754A1 Method for preparing low dosage entecavir formulation for oral administration
10/24/2013WO2013157665A1 Fatty acid derivative-polymer conjugate
10/24/2013WO2013157664A1 Tricyclo compound-polymer conjugate
10/24/2013WO2013157584A1 Encapsulated formulation
10/24/2013WO2013157034A1 Composition for preparing external skin preparation
10/24/2013WO2013156989A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids
10/24/2013WO2013156488A2 Optimised subcutaneous therapeutic agents
10/24/2013WO2013156453A1 Tamper resistant and dose-dumping resistant pharmaceutical dosage form
10/24/2013WO2013155586A1 Process for preparing inclusion compounds enclosing cyclodextrins and drugs, using a continuous-flow system
10/24/2013WO2013155585A1 Sustained release device for thalidomide and use in eye diseases causing neovascularisation
10/24/2013WO2013134407A3 Procaspase 3 activation by combination therapy
10/24/2013WO2013129889A3 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
10/24/2013WO2013111012A3 Methods and compositions for therapeutic agents
10/24/2013WO2013083910A3 Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants
10/24/2013WO2013076507A3 Platelet lysate gel
10/24/2013WO2012167079A3 Dermal filler compositions including antioxidants
10/24/2013WO2012131306A8 Pharmaceutical preparation
10/24/2013WO2012120364A8 Novel immediate release film coating composition and preparation process thereof
10/24/2013US20130281679 Conjugate for photodynamic diagnosis or therapy and method for preparing same
10/24/2013US20130281678 Process for preparing purified drug conjugates
10/24/2013US20130281673 Antibodies that bind cell-associated ca 125/o772p
10/24/2013US20130281658 Peptide-Based In Vivo siRNA Delivery System
10/24/2013US20130281646 Multifunctional linkers
10/24/2013US20130281637 Fatty acid derivative-polymer conjugate
10/24/2013US20130281566 Paste-Like Bone Cement
10/24/2013US20130281550 Carotenoid compositions containing octenyl succinate anhydride-modified gum acacia
10/24/2013US20130281548 Compositions comprising a combination of at least one colorant and at least one polysaccharide
10/24/2013US20130281547 Purified Amphiphilic Peptide Compositions and Uses Thereof
10/24/2013US20130281537 Aqueous liquid bromfenac composition having preservative efficacy
10/24/2013US20130281480 Oral Drug Delivery System
10/24/2013US20130281471 Acyclovir Formulations
10/24/2013US20130281431 Dna-pk inhibitors
10/24/2013US20130281424 Anti-bacterial siderophore-aminopenicillin conjugates
10/24/2013US20130281417 Implants and methods for treating inflammation-mediated conditions of the eye
10/24/2013US20130281416 Pharmaceutical composition
10/24/2013US20130281413 Salicylate Conjugates Useful For Treating Metabolic Disorders
10/24/2013US20130281382 Stable lipid-comprising drug delivery complexes and methods for their production
10/24/2013US20130281377 Treating multiple myeloma
10/24/2013US20130281364 Preparation Comprising Insulin, Nicotinamide and an Amino Acid
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 1712